InvestorsHub Logo
Followers 4
Posts 480
Boards Moderated 0
Alias Born 09/18/2017

Re: Rapture2020 post# 27062

Sunday, 12/10/2017 9:55:43 AM

Sunday, December 10, 2017 9:55:43 AM

Post# of 50157
Alternatives perhaps...Surgery, Oral Sorafenib or a full chemo but none as effective as targeted CS PHP..... Chemosat is prolonging life the maximum with only few side effects.Perhaps a combination of Sorafenib and side effects drugs can work with Delcath's patented targeted method. 28K cases diagnosed in the US in last year...all terminal....no much available. CS PHP appears most promising according to Jonathan Zager at Moffit Cancer Center, he is one of the six Medical advisors to Delcath.

http://delcath.com/profile/jonathan-s-zager-md/

Liver-directed high dose chemotherapy evolved from a highly invasive open surgical procedure to a minimally invasive procedure known as percutaneous hepatic perfusion (PHP). 

http://delcath.com/chemotherapy/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News